India to United States: Irinotecan Export Trade Route

The India to United States Irinotecan corridor is one of India's established pharmaceutical export routes, with 33 shipments documented worth a combined $2.2M USD. The route is dominated by EUGIA PHARMA SPECIALITIES LIMITED, which alone accounts for roughly 75% of all export value, reflecting the consolidated nature of India's irinotecan manufacturing sector.

Across 7 active suppliers, the average shipment value stands at $66.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with irinotecan's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 18.5%, placing it at rank #3 among India's top irinotecan export destinations globally.

On the import side, key buyers of Indian irinotecan in United States include EUGIA US LLC, EUGIA US LLC,, Xiromed LLC and 5 others. EUGIA US LLC is the single largest importer with 13 shipments valued at $1.1M USD.

India's irinotecan exports to United States are driven primarily by a handful of large-scale manufacturers. EUGIA PHARMA SPECIALITIES LIMITED with 22 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — EUGIA PHARMA SPECIALITIES LIMITED, GLAND PHARMA LIMITED, ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $66.7K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as irinotecan 20mg/5ml and irinotecan hydrochloride injection usp300mg/15 ml(irinotecan hydrochloride injection usp300 mg/15 ml (20mg/ml) - us), suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, EUGIA US LLC is the largest importer with 13 shipments worth $1.1M USD — representing 51% of all irinotecan imports from India on this route. A total of 8 buyers are active on this corridor.